U.S. flag

An official website of the United States government

NM_001002755.4(NFU1):c.-6A>G AND not provided

Germline classification:
Benign (1 submission)
Last evaluated:
Sep 15, 2017
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000676269.5

Allele description [Variation Report for NM_001002755.4(NFU1):c.-6A>G]

NM_001002755.4(NFU1):c.-6A>G

Genes:
LOC129934004:ATAC-STARR-seq lymphoblastoid active region 15971 [Gene]
NFU1:NFU1 iron-sulfur cluster scaffold [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p13.3
Genomic location:
Preferred name:
NM_001002755.4(NFU1):c.-6A>G
HGVS:
  • NC_000002.12:g.69437428T>C
  • NG_031931.1:g.5201A>G
  • NM_001002755.4:c.-6A>GMANE SELECT
  • NM_001002756.2:c.-383A>G
  • NM_001374284.1:c.-11+625A>G
  • NM_015700.4:c.-168A>G
  • NC_000002.11:g.69664560T>C
  • NM_001002755.2:c.-6A>G
  • NR_045631.2:n.8A>G
  • NR_045632.2:n.8A>G
Links:
dbSNP: rs116604978
NCBI 1000 Genomes Browser:
rs116604978
Molecular consequence:
  • NM_001002755.4:c.-6A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001002756.2:c.-383A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_015700.4:c.-168A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001374284.1:c.-11+625A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NR_045631.2:n.8A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_045632.2:n.8A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000802024Mayo Clinic Laboratories, Mayo Clinic
no assertion criteria provided
Benign
(Sep 15, 2017)
unknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Mayo Clinic Laboratories, Mayo Clinic, SCV000802024.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023